Skip to content
★ Sign in to follow
LG

Logos Global Master Fund LP

Related company / holding
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€1.9M
▼ Sales (0 ops.)
—

Latest filing published 16 Nov 2020 for Viridian Therapeutics, Inc.\DE, €231k.

Filing timeline

BuySale
Logos Global Master Fund LP

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-16.1%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Logos Global Master Fund LP: trading record in brief

This profile gathers the share dealings of Logos Global Master Fund LP in Viridian Therapeutics, Inc.\DE. Between 9 November 2020 and 13 November 2020, the trades on record add up to 3 filings.

The open-market record is one-sided, with 3 purchases worth €1.9M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €231k and half below. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month. Ninety days after publication, 3 purchases show a median change of -16.1%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 16 November 2020 with an open-market purchase (€231k) in Viridian Therapeutics, Inc.\DE. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Logos Global Master Fund LP

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total

3 of 3 declarations